SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "WFRF:(Guzik M.) srt2:(2015-2019)"

Search: WFRF:(Guzik M.) > (2015-2019)

  • Result 1-25 of 30
Sort/group result
   
EnumerationReferenceCoverFind
1.
  • 2017
  • swepub:Mat__t
  •  
2.
  •  
3.
  •  
4.
  •  
5.
  •  
6.
  •  
7.
  •  
8.
  •  
9.
  •  
10.
  • Siwowska, K., et al. (author)
  • Therapeutic Potential of Sc-47 in Comparison to Lu-177 and Y-90: Preclinical Investigations
  • 2019
  • In: Pharmaceutics. - : MDPI AG. - 1999-4923. ; 11:8
  • Journal article (peer-reviewed)abstract
    • Targeted radionuclide therapy with Lu-177- and Y-90-labeled radioconjugates is a clinically-established treatment modality for metastasized cancer. Sc-47 is a therapeutic radionuclide that decays with a half-life of 3.35 days and emits medium-energy beta(-)particles. In this study, Sc-47 was investigated, in combination with a DOTA-folate conjugate, and compared to the therapeutic properties of Lu-17-folate and Y-90-folate, respectively. In vitro, Sc-47-folate demonstrated effective reduction of folate receptor-positive ovarian tumor cell viability similar to Lu-177-folate, but Y-90-folate was more potent at equal activities due to the higher energy of emitted beta(-)particles. Comparable tumor growth inhibition was observed in mice that obtained the same estimated absorbed tumor dose (similar to 21 Gy) when treated with Sc-47-folate (12.5 MBq), Lu-177-folate (10 MBq), and Y-90-folate (5 MBq), respectively. The treatment resulted in increased median survival of 39, 43, and 41 days, respectively, as compared to 26 days in untreated controls. There were no statistically significant differences among the therapeutic effects observed in treated groups. Histological assessment revealed no severe side effects two weeks after application of the radiofolates, even at double the activity used for therapy. Based on the decay properties and our results, Sc-47 is likely to be comparable to Lu-177 when employed for targeted radionuclide therapy. It may, therefore, have potential for clinical translation and be of particular interest in tandem with Sc-44 or Sc-43 as a diagnostic match, enabling the realization of radiotheragnostics in future.
  •  
11.
  • Hill, JA, et al. (author)
  • Medical Misinformation
  • 2019
  • In: Circulation. Cardiovascular interventions. - 1941-7632. ; 12:2, s. e007796-
  • Journal article (other academic/artistic)
  •  
12.
  • Hill, JA, et al. (author)
  • Medical Misinformation
  • 2019
  • In: Hypertension (Dallas, Tex. : 1979). - 1524-4563. ; 73:3, s. 506-507
  • Journal article (other academic/artistic)
  •  
13.
  • Hill, JA, et al. (author)
  • Medical Misinformation
  • 2019
  • In: Circulation. Heart failure. - 1941-3297. ; 12:2, s. e005869-
  • Journal article (other academic/artistic)
  •  
14.
  • Hill, JA, et al. (author)
  • Medical Misinformation
  • 2019
  • In: Circulation. Cardiovascular imaging. - 1942-0080. ; 12:2, s. e008809-
  • Journal article (other academic/artistic)
  •  
15.
  • Hill, JA, et al. (author)
  • Medical Misinformation
  • 2019
  • In: Circulation. Genomic and precision medicine. - 2574-8300. ; 12:2, s. e002439-
  • Journal article (other academic/artistic)
  •  
16.
  • Hill, JA, et al. (author)
  • Medical Misinformation
  • 2019
  • In: Circulation. - 1524-4539. ; 139:5, s. 571-572
  • Journal article (other academic/artistic)
  •  
17.
  • Hill, JA, et al. (author)
  • Medical Misinformation
  • 2019
  • In: Circulation. Cardiovascular quality and outcomes. - 1941-7705. ; 12:2, s. e005496-
  • Journal article (other academic/artistic)
  •  
18.
  • Hill, JA, et al. (author)
  • Medical misinformation: vet the message!
  • 2019
  • In: Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing. - : Springer Science and Business Media LLC. - 1572-8595. ; 55:1, s. 1-3
  • Journal article (other academic/artistic)
  •  
19.
  • Hill, JA, et al. (author)
  • Medical misinformation: Vet the message!
  • 2019
  • In: Journal of electrocardiology. - : Elsevier BV. - 1532-8430 .- 0022-0736. ; 53, s. 112-113
  • Journal article (other academic/artistic)
  •  
20.
  •  
21.
  • Hill, JA, et al. (author)
  • Medical Misinformation: Vet the Message!
  • 2019
  • In: Cardiovascular drugs and therapy. - : Springer Science and Business Media LLC. - 1573-7241 .- 0920-3206. ; 33:3, s. 275-276
  • Journal article (other academic/artistic)
  •  
22.
  • Hill, JA, et al. (author)
  • Medical Misinformation: Vet the Message!
  • 2019
  • In: International journal of cardiology. - : Elsevier BV. - 1874-1754 .- 0167-5273. ; 277, s. 1-2
  • Journal article (other academic/artistic)
  •  
23.
  •  
24.
  •  
25.
  • Hill, JA, et al. (author)
  • Medical misinformation: vet the message!
  • 2019
  • In: European heart journal. Quality of care & clinical outcomes. - : Oxford University Press (OUP). - 2058-1742 .- 2058-5225. ; 5:2, s. 83-84
  • Journal article (other academic/artistic)
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-25 of 30

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view